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ABSTRACT
Recently, 5-hydroxymethylcytosine (5hmC) was
identified in mammalian genomic DNA. The bio-
logical role of this modification remains unclear;
however, identifying the genomic location of this
modified base will assist in elucidating its function.
We describe a method for the rapid and inexpensive
identification of genomic regions containing 5hmC.
This method involves the selective glucosylation of
5hmC residues by the b-glucosyltransferase from T4
bacteriophage creating b-glucosyl-5-hydroxymethy-
lcytosine (b-glu-5hmC). The b-glu-5hmC modifica-
tion provides a target that can be efficiently and
selectively pulled down by J-binding protein
1 coupled to magnetic beads. DNA that is
precipitated is suitable for analysis by quantitative
PCR, microarray or sequencing. Furthermore, we
demonstrate that the J-binding protein 1 pull down
assay identifies 5hmC at the promoters of develop-
mentally regulated genes in human embryonic stem
cells. The method described here will allow for a
greater understanding of the temporal and spatial
effects that 5hmC may have on epigenetic regula-
tion at the single gene level.
INTRODUCTION
DNA methylation at cytosine residues in mammalian cells
is a well known and well described modiﬁcation affecting
gene expression. This DNA modiﬁcation consists of
a cytosine that is modiﬁed by a methyl group at the N5
position (5meC). The 5meC modiﬁcation generally occurs
at the CpG dinucleotide sequence; however, the 5meC
modiﬁcation has been identiﬁed elsewhere in the genome
[For a recent review see ref. (1)].
Two independent groups recently discovered another
type of DNA modiﬁcation that is speculated to be
involved in gene regulation, 5-hydroxymethylcytosine
(5hmC) (2,3). Tahiliani et al. (2) demonstrated that the
enzyme Tet1, an iron-dependent a-ketoglutarate dioxyge-
nase, catalyzes the formation of 5hmC from 5meC.
Furthermore, this group suggested that the 5hmC base
may be an intermediate in the conversion of 5meC to
cytosine, thus identifying an enzyme that can potentially
demethylate DNA (2). Kriaucionis and Heintz
demonstrated that 5hmC is a stable DNA modiﬁcation
found in specialized non-dividing neurons and was likely
present in the animal tissues they studied. Further studies
have conﬁrmed the presence of 5hmC in these mammalian
tissues (4,5). Intriguingly, 5hmC was not detected in can-
cerous cell lines. The inability to detect 5hmC in cancerous
cell lines suggests that the lack of 5hmC may be involved
in tumorigenesis (3). This result also allows for speculation
that 5hmC is involved in epigenetic gene regulation.
This alleged involvement of 5hmC in epigenetic regulation
has been experimentally veriﬁed by Jin et al. who show
that 5hmC in DNA inhibits the binding of several
methyl-CpG-binding domain proteins (6)—proteins that
are known to regulate transcription by interaction with
5meC (7). Further research by Ito et al. has shown that
Tet2 and Tet3 also catalyze the formation of 5hmC (8).
Additionally, two independent groups have been able to
precisely quantify the amount of 5hmC present in several
mammalian tissues (9–11); however, the speciﬁc genomic
location of 5hmC remains unknown.
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ing 5hmC has been shown to be technically challenging.
The most frequent method of identifying 5meC, bisulﬁte
sequencing, cannot distinguish 5meC from 5hmC (11–13).
Furthermore, it has been questioned whether commer-
cially available antibodies raised against 5hmC can distin-
guish between 5meC and 5hmC (8). We note that Ko et al.
have developed an antiserum that recognizes
5-methylenesulfonate, the product of bisulﬁte conversion
of 5hmC and therefore this antiserum may prove useful
for identifying the location of 5hmC (14). Using polymer-
ase kinetics one group has been able to differentiate
between 5meC and 5hmC using model substrates (15).
This sequencing method may prove useful for genome
wide analysis; however, it requires specialized and expen-
sive equipment making this method impractical for iden-
tiﬁcation of the 5hmC status of individual genes and has
yet to be demonstrated in in vivo studies (11). With these
difﬁculties in mind we tried to develop a simple and
cost-effective means of identifying the 5hmC-containing
genomic regions.
The DNA of wild-type bacteriophage T4 is nearly
devoid of cytosine residues, which are replaced by
5hmC. Furthermore, these 5hmC residues are gluco-
sylated by the T4-encoded a-glucosyltransferase or
b-glucosyltransferase (16), the latter proving more efﬁcient
when used for in vitro glucosylation assays (9,17,18). We
have exploited the glucosylation of 5hmC residues to mark
5hmC residues in mammalian DNA. Glucosylated 5hmC
is chemically similar to b-glucosyl-5-hydroxymethyluracil,
which is speciﬁcally recognized by DNA binding proteins
from certain protozoa.
African trypanosomes and related kinetoplastids
contain the highly modiﬁed base b-glucosyl-5-
hydroxymethyluracil (often referred to as the J-base) in
their DNA (19–21). These organisms contain J-binding
proteins (JBP1 and JBP2) and notably JBP1 speciﬁcally
binds to DNA containing the J-base (22–24). Given that
JBP1 is able to bind J-containing DNA we reasoned
that JBP1 may be able to cross-react signiﬁcantly
with b-glucosyl-5-hydroxymethylcytosine (b-glu-5hmC)
containing DNA.
We show here that 5hmC can be selectively identiﬁed in
genomic regions (Figure 1) by modifying 5hmC residues
in genomic DNA using the T4 b-glucosyltransferase (b-gt)
to create b-glu-5hmC residues. DNA containing these
residues can be pulled down with J-binding protein 1
(JBP1) from Crithidia fasciculate, allowing for the efﬁcient
identiﬁcation of genomic regions containing 5hmC.
Importantly, the JBP1 pull down assay was applied to
identify 5hmC at promoters of developmentally regulated
genes in human embryonic stem (hES) cells. This report is,
to our knowledge, the ﬁrst to identify the location of
5hmC in any genome.
MATERIALS AND METHODS
Protein puriﬁcations
 -Glucosyltransferase. The bgt gene was ampliﬁed from
T4 bacteriophage DNA and was cloned into pET28a.
Cultures of Rosetta(DE3)pLysS harboring pET28a-bgt
were grown in 500ml Studier auto-inducing media (25)
to an A600 of 0.6 at 37 C followed by a shift to 18 C for
20h. The cells were harvested by centrifugation and sus-
pended in 10ml b-gt lysis buffer [500mM NaCl, 25mM
Hepes KOH (pH 7.9), 5mM imidazole, 10% (v/v)
glycerol]. All subsequent steps were carried out at 4 C
unless otherwise speciﬁed.
After suspension in lysis buffer, cells were incubated
for 1h with lysozyme added to a ﬁnal concentration of
200mg/ml. After 1h Triton-X100 was added to the lysate
to a ﬁnal concentration of 0.1% (v/v) and the lysate was
heated brieﬂy to 20 C. The lysate viscosity was reduced by
sonication on ice. The lysate was clariﬁed by centrifuga-
tion for 60min at 20000rpm in a SS34 rotor (Sorvall).
After centrifugation the supernatant was applied and
batch bound for 1h to 2ml of Talon Resin (GE
Healthcare) equilibrated in b-gt lysis buffer. The lysate
was applied to a column and washed with b-gt lysis
buffer until the ﬂow through had had an A280 of 0. b-gt
was eluted with 20ml b-gt lysis containing 200mM
imidazole.
Fractions containing the highest concentration of
protein were pooled and dialyzed 3 times against 100
volumes of b-gt low salt buffer [50mM NaCl, 25mM
Hepes KOH (pH 7.9), 0.5mM EDTA (pH 8.0), 10%
(v/v) glycerol]. The pool was then applied to a Resource
S cation exchange column. The column was eluted with a
50–500mM linear NaCl gradient. Relevant fractions were
pooled and dialyzed against 100 volumes b-gt storage
buffer [250mM NaCl, 25mM Hepes KOH (pH 7.9),
1mM EDTA (pH 8.0), 50% (v/v) glycerol].
J-binding protein 1. The gene coding for J-binding protein
1 (JBP1) from C. fasciculata was synthesized by GeneArt
(Germany). After synthesis the gene was cloned into
pET28a. Cultures of Rosetta(DE3)pLysS harboring
pET28a-JBP1 were grown in 500ml Studier auto-inducing
media to an OD A600 of 0.6 at 37 C followed by a shift to
18 C for 20h. The cells were harvested by centrifugation
and suspended in 10ml JBP1 lysis buffer [500mM NaCl,
25mM Tris-HCl (pH 7.5), 5mM imidazole, 10% (v/v)
glycerol]. All subsequent steps were carried out at 4 C
unless otherwise speciﬁed.
After suspension in JBP1 lysis buffer, cells were
incubated for 1h with lysozyme added to a ﬁnal concen-
tration of 200mg/ml. After 1h Triton-X100 was added to
the lysate to a ﬁnal concentration of 0.1% (v/v) and the
lysate was heated brieﬂy to 20 C. The lysate viscosity was
reduced by sonication on ice. The lysate was clariﬁed by
centrifugation for 10min at 10000rpm in a SS34 rotor
(Sorvall). After centrifugation the supernatant was
applied and batch bound for 1h to 2ml of Talon Resin
(GE Healthcare) equilibrated in JBP1 lysis buffer. The
lysate was applied to a column and washed with JBP1
lysis buffer until the ﬂow through had an OD A280 of 0.
JBP1 was eluted with 20ml JBP1 lysis buffer containing
200mM imidazole.
Fractions containing the highest concentration of
protein were pooled and concentrated to 500ml using a
centricon MWCO 30000 according to the manufacturer’s
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a Superdex75 size exclusion column and eluted with
JBP1 Superdex Buffer [250mM NaCl, 25mM Tris-HCl
(pH 7.5), 1mM EDTA (pH 8.0), 1mM DTT, 10% (v/v)
glycerol]. Fractions containing no detectable contamin-
ants (as judged by SDS–PAGE) were pooled and 3 times
dialyzed against 100 volumes PBS [150mM NaCl, 50mM
KPO4 (pH 7.2)].
Coupling JBP1 to magnetic beads
Five milligrams of Epoxy modiﬁed magnetic beads
(Dynal, Oslo, Norway) were equilibrated according to
the manufacturer’s instructions and suspended in 60ml
PBS. About 100mg of JBP1 in PBS was added to the
beads and the PBS was added until the volume equaled
120ml, followed by the addition of 40ml 4M (NH4)2SO4.
The bead/JBP1 solution was slowly rotated at 4 C for
48h. After incubation, the protein not bound to the
beads was removed and binding efﬁciencies were
calculated (typical binding efﬁciencies were between 70
and 80%). The beads were then blocked with 300ml
binding buffer [2mM EDTA (pH 8.0), 10mM Tris
(pH 8.0), 150mM NaCl, 0.02% (v/v) Tween-20, 1mg/ml
BSA]. After blocking beads were washed three times with
300ml binding buffer and ﬁnally suspended in 300ml
binding buffer. Beads were prepared freshly for each ex-
periment as it was found that several freeze thaw cycles
dramatically reduced binding capacity.
Substrates
Oligonucleotide substrates. Annealing reactions (50ml)
containing 100pmol of each complementary oligonucleo-
tide (Supplementary Table S1), 40mm Tris–HCl (pH 7.5),
10mM MgCl2, 1mM dithiothreitol, 50mM NaCl were
heated to 95 C in a thermocycler for 5min followed
decrease in temperature of 1 C/min to 25 C. Duplex
Figure 1. Scheme for the selective pull down of 5hmC. The top panel shows the known naturally occurring cytosine modiﬁcations in mammalian
cells. The middle panel gives an overview of the method used to speciﬁcally identify 5hmC bases in genomic DNA. The bottom panel shows some
applications that can be employed using this method of identifying 5hmC regions.
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denaturing PAGE according to the protocol established
by Sambrook et al. (26).
PCR ampliﬁed substrates. Substrates containing cytosine
residues or 5meC residues were ampliﬁed from pUC18 or
from speciﬁc mouse genomic regions (Supplementary
Table S2) using a PCR reaction containing unmodiﬁed
dNTPs with Pfu Turbo (Stratagene) according to the
manufacturer’s instructions. 5meC residues were created
by incubating the PCR product ampliﬁed using unmodi-
ﬁed dNTPs with M. SssI methyltransferase (NEB) accord-
ing to the manufacturer’s instructions. Substrates
containing 5hmC residues or b-glu-5hmC residues were
ampliﬁed as other substrates except that d5hmCTP
(Bioline) was used in place of dCTP. b-glu-5hmC sub-
strates were generated by incubating the PCR product
created using d5hmCTP with 10mg b-gt, 20mM
UDP-glucose (Sigma) in b-gt reaction buffer [20mM
KPO4 (pH 8.0), 25mM MgCl2]. Substrates were puriﬁed
on a 0.8% agarose gel and excised using a gel extraction
kit (Qiagen).
Radiolabeled substrates. Reactions (50ml) containing 1mg
DNA substrate, 10mCi g-[
32P]ATP, 2.5 U T4 polynucleo-
tide kinase (NEB) and buffer supplied by the manufactur-
er were incubated at 37 C for 30min. After 30min
100mmol ATP was added and the reaction was allowed
to proceed for 10min. Enzyme and free nucleotide was
removed using a nucleotide removal kit (Qiagen).
b-gt speciﬁcity and activity assay
Reactions (50ml) containing 1pmol double stranded oligo-
nucleotide substrate, 20mM UDP-glucose, 10mg b-gt and
b-gt reaction buffer were incubated at 37 C for 60min.
Reactions were terminated by the addition of 10ml Stop
Buffer [20mg Protenase K, 50mM Tris–HCl (pH 8.0),
100mM EDTA (pH 8.0), 2% (w/v) SDS] followed by
incubation at 42 C for 60min. Oligonucleotides were
puriﬁed by phenol:CHCl3:IAA extraction followed by an
ethanol precipitation. Pellets were suspended in 50ml NEB
buffer 4 and 10U TaqI (NEB) and were allowed to
incubate at 65 C for 16h. TaqI was inactivated by
heating to 80 C for 20min followed by an incubation
with 2.5U of shrimp alkaline phosphatase (NEB) for
30min. The alkaline phosphatase was inactivated by
heating to 65 C for 5min. Reactions were radiolabeled
by adding 2.5U T4 polynucleotide kinase, 10mCi g-[
32P]-
ATP and the volume was raised to 70ml with T4 poly-
nucleotide kinase buffer. DNA was cleaned by
phenol:CHCl3:IAA (isoamyl alcohol) extraction followed
by an ethanol precipitation. Pellets were suspended in 5ml
DNase I buffer and 0.2 U DNase I (NEB) and 0.2 U snake
venom phosphodiesterase (Worthington) was added to the
reactions. Reactions were incubated at 25 C for at least
4h. About 0.5ml of each reaction was spotted onto a
100 20 20cm cellulose thin layer plate. The nucleotides
were resolved in two phases: the ﬁrst phase contained
isobutyric acid:water:NH3 (66:20:1) the second phase
contained 4M ammonium sulfate: 1M acetic acid:
isopropanol (80:17:2). Radioactive spots were identiﬁed
using a phosphor screen.
LC/MS/MS analysis
DNA substrates were composed of 2.7kb linear pUC18
PCR products that contained only cytosines, 5meC at
CpG regions, only 5hmC, or the same three DNA
substrates treated with 100ng b-gt in the presence of
20mM UDP-glucose. Substrates were hydrolyzed to nu-
cleosides by incubation with nuclease P1, snake venom
phosphodiesterase and alkaline phosphatase (Sigma-
Aldrich, St Louis, MO, USA) as described (27). Three
volumes of methanol were added to the reactions
after digestion was completed and the reactions were
centrifuged at 16000g for 30min. The supernatants
were dried under vacuum and the resulting residues
were dissolved in 50ml 5% (v/v) methanol for analysis
by LC/MS/MS. Chromatographic separation of nucleo-
sides was performed using a Shimadzu Prominence
HPLC system with a Zorbax SB-C18 2.1 150mm i.d.
(3.5mm) reverse phase column equipped with a Eclipse
XDB-C8 2.1 12.5mm i.d. (5mm) guard column
(Agilent Technologies, USA), with a ﬂow rate of 0.2ml/
min at ambient temperature. The mobile phase consisted
of A (0.1% formic acid in water) and B (0.1% formic acid
in methanol), starting with 95% A/5% B for 0.5min,
followed by a 6.5-min linear gradient of 5–50% B, 2min
with 50% B and 6min re-equilibration with the initial
mobile phase conditions. Online mass spectrometry detec-
tion was performed using an Applied Biosystems/MDS
Sciex 5000 triple quadrupole mass spectrometer (Applied
Biosystems Sciex, USA) with TurboIonSpray probe
operating in positive electrospray ionization mode. The
deoxyribonucleosides were monitored by multiple
reaction monitoring using the mass transitions 228.2!
112.1 (dC), 242.2!126.1 [5-me(dC)], 258.2!142.1
[5-hm(dC)] and 420.2!304.1 [5-Gly-hm(dC)].
JBP1 pull down reactions
Pull down reactions (200ml) containing 132ng JBP1
coated beads and 10ng radiolabeled DNA when using
PCR ampliﬁed substrates or 208fmol 37mer, binding
buffer [2mM EDTA (pH 8.0), 10mM Tris–HCl (pH 8.0)
150mM NaCl, 0.02% (v/v) Tween-20, 1mg/ml BSA] were
incubated for 60min at room temperature with gentle
rotation. After incubation the supernatant was collected
and counted by scintillation counting. The JBP1 coated
beads were washed three times with 300ml binding buffer
without BSA. Radioactivity bound to the beads was
counted using scintillation counting.
qPCR varying bead concentrations
Reactions (200ml) contained 10ng of each DNA substrate
combined in one vial, with binding buffer and varying
amounts of JBP1 modiﬁed magnetic beads were incubated
for 60min at room temperature with gentle rotation. After
washing three times with 300ml binding buffer without
BSA and the beads were suspended in 90ml binding
buffer and 10ml stop buffer was added [20mg/ml
Proteinase K, 50mM Tris–HCl (pH 8.0), 100mM
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at 42 C for 60min. After incubation the DNA was cleaned
using a PCR clean kit (Qiagen) and the amount of each
DNA pulled down relative to the input was measured by
quantitative real-time PCR.
Complete glucosylation and pull down assay
Reactions (50ml) containing 20ng of each of three DNA
substrates (unmodiﬁed cytosine, 5meC, 5hmC genomic
regions combined in one vial), 20mM UDP-Glucose and
b-gt reaction buffer, and either 10mg b-gt or b-gt storage
buffer were incubated at 37 C for 30min. Reactions were
stopped by the addition of 10ml stop buffer. DNA was
puriﬁed using a PCR clean kit (Qiagen). The cleaned
DNA was incubated with 20mg JBP1 coated magnetic
beads in 200ml binding buffer for 60min with gentle
rotation. Beads were washed thre times with 300ml
binding buffer without BSA and the beads were suspended
in 90ml binding buffer and incubated at 42 C for 60min
with 10ml stop buffer. DNA was then cleaned using a
PCR clean kit. The amount of each DNA pulled down
relative to the input was quantiﬁed using real-time PCR.
The fold enrichment above cytosine was calculated by
dividing each pulled down amount by the amount of
cytosine containing DNA pulled down.
JBP1 pull down of 5hmC from human ES cell
genomic DNA
Puriﬁed human ES cell DNA was sonicated on ice using a
probe sonicator (Labsonic-M, 3-mm probe; cycle 0.5, 30%
power; Sartorius AG, Go ¨ ttingen, Germany) to produce an
average fragment length of 300bp. One microgram of this
DNA was treated with b-gt and subjected to JBP1 pull
down as described above except the reactions contained
264ng JPB1 coated magnetic beads. Negative controls
were performed without the addition of b-gt. JBP1-
bound DNA was puriﬁed and used as template in
qPCR. Quantitative PCR primers used in this study
were as described (28,29) or are shown in Supplementary
Table S1.
RESULTS
A brief overview of our scheme to speciﬁcally identify
genomic regions containing 5hmC residues is shown
(Figure 1). Brieﬂy, we use the b-gt to speciﬁcally modify
5hmC residues creating b-glu-5hmC residues. Following
the complete conversion of 5hmC to b-glu-5hmC we
incubate the DNA with JBP1-coated magnetic beads.
JBP1 speciﬁcally binds b-glu-5hmC containing DNA
allowing for efﬁcient and selective identiﬁcation of DNA
containing 5hmC. The resulting DNA is puriﬁed and
ready for analysis by various methods.
The b-glucosyltransferase speciﬁcally glucosylates 5hmC
Recombinant b-gt from phage T4 was expressed and
puriﬁed to >90% purity (Supplementary Figure S1;
lane 1) by Cobalt afﬁnity chromatography, followed by
cation exchange chromatography. The b-gt has been
shown by many groups to speciﬁcally glucosylate 5hmC
residues(16–18); yet, we tested the efﬁciency and speciﬁcity
of our puriﬁed enzyme to ensure that our puriﬁcation
scheme resulted in active T4 b-gt. Three double-stranded
37-bp substrates were created: one contained unmodiﬁed
cytosine at a TaqI restriction site, the second contained
5meC at the TaqI site and the third contained a 5hmC
at the TaqI site. Each of the three substrates was treated
with puriﬁed b-gt in the presence of UDP-glucose or
incubated in the absence of b-gt. The resulting products
were digested with TaqI, treated with alkaline phosphat-
ase, 50-end labeled using T4 polynucleotide kinase and
digested to 50-mononucleotides using DNase I and
Snake Venom Phosphodiesterase. The resulting nucleo-
tides were then resolved using two-dimensional thin-layer
chromatography (TLC). From the TLC analysis we
deduced that the b-gt has no effect on the substrates
that lack 5hmC (Figure 2a; left and center); however,
upon treatment with b-gt the 5hmC spot is absent from
the TLC plate (Figure 2a; right); this result strongly
suggests that the 5hmC has been speciﬁcally modiﬁed by
the b-gt, demonstrating that b-gt is active. The cytosine
and thymidine spots are good reference markers and are
present because the substrates terminate with 50-cytosine
and 50-thymidine residues. Additionally, we performed
mass spectrometry on each of the substrates to reinforce
that the b-gt can convert 5hmC residues to b-glu-5hmC at
nearly 100% efﬁciency (Figure 2b and Supplementary
Figure S2).
JPB1 from C. fasciculata can speciﬁcally pull down
b-glucosyl-5hmC
Recombinant C. fasciculata JBP1 containing a his-tag was
puriﬁed to >90% homogeneity by cobalt afﬁnity chroma-
tography followed by size exclusion chromatography.
Fractions included in the ﬁnal pool of puriﬁed JBP1
were determined to be free of detectable nucleases
(Supplementary Figure S1; lane 2). Following puriﬁcation,
JBP1 was covalently linked to epoxy modiﬁed magnetic
beads (‘Materials and Methods’ section).
JBP1 coated magnetic beads were incubated with
four different radiolabeled substrates and precipitated
using a magnet. Each substrate was a 2.7kb linear PCR
product created using pUC18 as a template (Supple-
mentary Table S1). The substrates contained normal
adenines (A), guanines (G) and thymidines (T) and either:
only cytosine residues, 5meC residues in CpG sequences,
only 5hmC residues or b-glu-5hmC residues produced by
incubating the 5hmC substrate with the b-gt. JBP1 coated
magnetic beads (132ng) could effectively pull down up to
6% of the DNA that contained the b-glu-5hmC modiﬁca-
tion (Figure 3a). Additionally, JBP1 had little afﬁnity
for cytosine, 5meC or 5hmC containing substrates.
Furthermore, BSA coated magnetic beads were unable to
pulldownany ofthe substrates, suggesting thatthe binding
ofb-glu-5hmC isduetoJBP1 boundtothemagnetic beads.
The efﬁciency of b-gly-5hmC pull down is dependent
on the amount of JBP1 coated magnetic beads
Four different DNA substrates were created by PCR
ampliﬁcation of four different 2kb mouse genomic
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tained 5meC at CpG dinucleotides, Sub3 5hmC: contained
5hmC instead of cytosines, Sub4 b-glu-5hmC: contained
b-glu-5hmC instead of cytosines—sequences are provided
in Supplementary Table S2). These four substrates were
incubated together with various concentrations of JBP1
coated magnetic beads. The beads were pulled down and
the amount of each substrate captured was quantiﬁed
using real-time quantitative PCR. There is a clear depend-
ence on the amount of JBP1 coated magnetic beads and
Figure 2. The b-gt can speciﬁcally modify 5hmC residues at a high efﬁciency. (a) Oligonucleotides that were either incubated in the presence or
absence of the b-gt were digested with TaqI, treated with alkaline phosphatase, 50-end labeled using T4 polynucleotide kinase and digested to
50-mononucleotides using DNase I and Snake Venom Phosphodiesterase. Radiolabeled mononucleotides were analyzed by two-dimensional TLC. C,
30-deoxyribocytosine-50-monophosphate; T, 30-deoxyribothymidine-50-monophosphate; 5meC, 30-deoxyribo-N5-methylcytosine-50-monophosphate;
5hmC, 30-deoxyribo-N5-hydroxymethylcytosine-50-monophosphate. (b) HPLC coupled to tandem mass spectrometry was used to measure the efﬁ-
ciency of the b-gt reaction. Substrates analyzed were 2.7kb linear PCR products of pUC18: the dC substrate contained only cytosine residues;
the 5meC substrate was created by methylating the CpG dinucleotide of the cytosine substrate; the 5hmC substrate was created by using d5hmC
in place of dCTP in the PCR reactions; the b-glu-5hmC substrate was created by incubating the 5hmC substrate with the b-gt in the presence of
UDP-glucose. Control DNA was prepared from salmon sperm. LC/MS/MS chromatograms of the cytosine residues from each of the substrates are
presented. Abbreviations: dC, 30-deoxyribocytosine; 5me(dC), 30-deoxyribo-N5-methylcytosine; 5hm(dC), 30-deoxyribo-N5-hydroxymethylcytosine;
5-glu-hm(dC), 30-deoxyribo-N5-(b-D-glucosyl(hydroxymethyl))cytosine. Asterisks indictes that cytosines are only 5meC modiﬁed at CpG sequences.
e55 Nucleic Acids Research, 2011,Vol. 39,No. 8 PAGE 6 OF 10the pull down efﬁciency (Figure 3b). Furthermore we dem-
onstrate that the highest concentration of JBP1 coated
magnetic beads can pull down 14% of the b-glu-5hmC
DNA and provide an 87-fold enrichment of b-glu-5hmC
modiﬁed DNA over cytosine containing DNA and a
319-fold enrichment over 5meC containing DNA.
JBP1 can pull down DNA containing a symmetrical
b-glu-5hmC modiﬁcation
The previous experiments were conducted using sub-
strates that contained many b-glu-5hmC modiﬁcations.
We wanted to determine if a symmetrical b-glu-5hmC
residue is sufﬁcient for recognition by JBP1 coated
magnetic beads. Therefore, we created four double
stranded 37bp substrates (Supplementary Table S1): the
ﬁrst contained unmodiﬁed cytosines, the second contained
a symmetrical 5meC modiﬁcation on each strand, the
third contained a symmetrical 5hmC modiﬁcation on
each strand and the fourth contained a symmetrical
b-glu-5hmC on each strand. Each of these substrates
was
32P end labeled and incubated with 132ng JBP1
coated beads. After the substrate was incubated with
JBP1 the bound fraction was measured by scintillation
counting. JBP1 coated magnetic beads pull down the sub-
strate containing a symmetrically modiﬁed b-glu-5hmC
efﬁciently while showing little afﬁnity for the other sub-
strates composed of an identical sequence (Figure 3c).
JBP1 preferentially pulls down b-glu-5hmC containing
DNA from a mixture of competing DNA substrates
We performed an assay that mimicked the JBP1 pull down
that will be used on mammalian DNA. We combined
several different mixtures of three DNA substrates
(Supplementary Table S2) with differing sequences, with
each substrate mixture containing unmodiﬁed cytosine
substrate, 5meC modiﬁed substrate and 5hmC modiﬁed
substrate. We then treated the substrate mixes with
puriﬁed b-gt in the presence of UDP-glucose. The
Figure 3. JBP1 can selectively pull down DNA that contains b-glu-5hmC resulting from b-gt treatment (a) Ten ng of each radiolabeled PCR product
(‘Materials and Methods’ section) was incubated with magnetic beads coated with 132ng JBP1 or 132ng BSA. The beads were pulled down with a
magnet and the percent bound to the beads was measured using scintillation counting. (b) Ten ng of each substrate were incubated in the same tube
with various concentrations of JBP1 coated magnetic beads. The beads were pulled down using a magnet and the DNA that was bound to the
magnetic beads was measured by quantitative real-time PCR. (c) 208fmol of 37bp double stranded oligonuleotides containing unmodiﬁed cytosines,
a single 5meC, 5hmC or b-glu-5hmC on each strand were incubated with 132ng JBP1 coated magnetic beads. Beads were pulled down as described
and the percent DNA bound to the JBP1 coated magnetic beads were quantiﬁed using scintillation counting. (d) Three different combinations of
three different PCR products composed of only cytosines, only 5meC, or 5hmC (20ng of each) were combined and incubated with puriﬁed b-gt in
the presence of UDP-Glucose. The DNA was puriﬁed and incubated with 132ng JBP1 coated magnetic beads. The JBP1 magnetic beads were pulled
down as above and the amount of DNA pulled down was quantiﬁed using quantitative real-time PCR. Data is presented as the fold enrichment over
cytosine-containing DNA.
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JBP1 coated magnetic beads. In all three mixtures tested,
the JBP1 coated magnetic beads were able to signiﬁcantly
enrich for the DNA substrate that contained the 5hmC
modiﬁcation after treatment with the b-gt (Figure 3d).
The data presented does not suggest an absolute
sequence independence for b-glu-5hmC modiﬁed DNA;
however, JBP1 has been previously shown to bind DNA
containing the J-base in a sequence independent manner
(22,23). Taken together, these results suggest that JBP1
binding to DNA is not dependent on sequence. Further
study on the binding properties of JBP1 to b-glu-5hmC
will be necessary to conﬁrm JBP1 binding in a sequence
independent manner.
The JBP1 pull down assay enables identiﬁcation of 5hmC
on the promoters of developmentally regulated genes
in human embryonic stem cells
The in vitro validated JBP1 pull down assay was applied
to assess the location of 5hmC in genomic DNA from
hES cells. One microgram of puriﬁed DNA sonicated to
an average fragment length of 300bp was treated with b-gt
and subjected to JBP1 pull down as described above.
Negative controls were performed without the addition
of the b-gt. This unglucosylated DNA will not be specif-
ically pulled down by JBP1, providing a background pull
down level. JBP1 bound DNA was puriﬁed and used as
template for qPCR. Quantitative PCR analysis (Figure 4)
revealed that the 5hmC levels at the promoters of the
housekeeping genes GAPDH, ACTB and UBE2B was at
or slightly above the background pull down seen in the
unglucosylated samples, suggesting that these promoters
do not contain 5hmC. In contrast, promoters of the
pluripotency marker genes KLF4, SOX2, OCT4
(POU5F1) and NANOG were enriched for 5hmC 7- to
14-fold above the unglucosylated pull down level,
showing that 5hmC is present at the promoters of these
genes. Moreover, genes which are expressed upon lineage
speciﬁc differentiation: MYOG, myogenic lineage; PAX6,
neurogenic lineage; LEP and FABP4, adipogenic lineage,
Figure 4. JPB1 can speciﬁcally pull down genomic DNA from human embryonic stem cells that has been incubated with the b-glucosyltransferase.
One microgram of genomic DNA from hES cells was incubated in the presence (blue bars) or in the absence (red bars) of the b-glucosyltransferase. After
incubation DNA was incubated and pulled down with JBP1 coated magnetic beads. The amount of DNA pulled down was quantiﬁed by real-time PCR.
The genomic location of the PCR ampliﬁed region relative to the transcription start site is shown for all loci in the top panel. Data is represented as fold
enrichment above background pull down. Error bars represent the standard deviation from the mean of at least three experiments.
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enrichment over background, at their promoters. In
summary, all developmentally regulated loci assessed
harbored 5hmC in human ES cells whereas the promoters
of cellular housekeeping genes lacked the 5hmC
modiﬁcation.
DISCUSSION
In this study we have developed a novel method for efﬁ-
cient and selective identiﬁcation of 5hmC modiﬁed nucleo-
tides in genomic DNA. At the present time the only other
method available to recognize the location of 5hmC modi-
ﬁcations—using polymerase kinetics—is prohibitively
expensive and has yet to be demonstrated in in vivo
studies(11). Currently, there is no antibody that has been
shown to speciﬁcally react with 5hmC; rather the current
literature shows that the commercially available antisera
raised against 5hmC cross-reacts signiﬁcantly with 5meC
(8). Furthermore, a 5hmC residue produces similar results
as a 5meC residue when bisulﬁte sequencing is employed
to identify these residues (12), rendering these approaches
to identifying 5hmC unusable without signiﬁcant im-
provements. However, an antiserum has been developed
that recognizes 5-methylenesulfonate, the product of
bisulﬁte conversion of 5hmC, this antiserum may prove
useful for identifying the location of 5hmC (14).
The method presented in this article ensures that only
5hmC-containing genomic regions will be precipitated and
identiﬁed in subsequent assays. Given that the b-gt
from T4 speciﬁcally catalyzes the glucosylation of 5hmC
[Figure 2 (16)] and JBP1 speciﬁcally recognizes the result-
ing b-glu-5hmC base (Figure 3a–d), the DNA pulled down
by JBP1 is highly enriched in the 5hmC modiﬁcation. The
pulled down DNA is then ready for analysis by real-time
quantitative PCR, microarray analysis, or sequencing by
any method, including high-throughput sequencing.
This report is, to our knowledge, the ﬁrst assessment of
the location of 5hmC in any genome. We demonstrate that
the JBP1 pull down assay can identify 5hmC at the pro-
moters (Figure 4) of developmentally regulated genes in
human embryonic stem cells, whereas the promoters of
housekeeping genes assayed do not appear to contain
the 5hmC modiﬁcation. Interestingly, the absence of
5hmC at promoters of the studied housekeeping genes
suggests that 5hmC does not directly correlate with gene
expression. Moreover, 5hmC is observed at the promoters
of genes that are not expressed in hES cells but that are
expressed during lineage speciﬁc differentiation. However,
pluripotency related genes are both expressed and show
promoter enrichment for 5hmC.
More simplistically, one might have envisaged a generic
role for 5hmC in transcriptional activation. Given that
promoter methylation generally has a transcriptionally re-
pressive role facilitated by the recruitment of methyl-CpG-
binding domain proteins and given that 5hmC inhibits the
binding of these proteins it was speculated that 5hmC may
enhance transcription (1). Some of the genes analyzed
for 5hmC content are transcriptionally silent in hES cells
yet primed for transcriptional activation; therefore, it is
tempting to speculate that the 5hmC modiﬁcation may
prime these genes for activation during differentiation.
Indeed, our data does not exclude the possibility that
5hmC may have a more direct role in the activation of
some genes or particular groups of genes. An alternative
scenario posits that 5hmC, rather than being an activating
mark by itself, sets up a transcriptional permissive envir-
onment that allows for further transcriptional directions
to be provided by other cellular factors or modiﬁcations.
More study into the relationship between 5hmC at pro-
moters and gene expression is necessary to validate either
of these hypotheses.
The simple and cost-effective method for identifying
genomic regions containing 5hmC presented in this
report will allow further investigation of the scenarios
outlined above and will signiﬁcantly increase the ability
of researchers to study the temporal and spatial patterns
of 5hmC residues in any genomic DNA.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We thank Kenneth Kreuzer (Duke University) for
providing us with wild-type T4 bacteriophage and Piet
Borst (The Netherlands Cancer Institute) for providing
experimental assistance and helpful advice. We also
would like to thank Rune Ougland for providing us with
human embryonic stem cell DNA.
FUNDING
Funding for open access charge: The Norwegian Research
Council and The Norwegian Cancer Society; the FRIBIO
and FUGE programs in the Research Council of Norway,
as well as Grant PNRF-143-1/07 from the Polish-
Norwegian Research Fund (to A.K.).
Conﬂict of interest statement. A provisional patent for the
use of the method described in this article has been
submitted.
REFERENCES
1. Illingworth,R.S. and Bird,A.P. (2009) CpG islands–‘a rough
guide’. FEBS Lett., 583, 1713–1720.
2. Tahiliani,M., Koh,K.P., Shen,Y., Pastor,W.A., Bandukwala,H.,
Brudno,Y., Agarwal,S., Iyer,L.M., Liu,D.R., Aravind,L. et al.
(2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine
in mammalian DNA by MLL partner TET1. Science, 324,
930–935.
3. Kriaucionis,S. and Heintz,N. (2009) The nuclear DNA base
5-hydroxymethylcytosine is present in Purkinje neurons and
the brain. Science, 324, 929–930.
4. Munzel,M., Globisch,D., Bruckl,T., Wagner,M., Welzmiller,V.,
Michalakis,S., Muller,M., Biel,M. and Carell,T. (2010)
Quantiﬁcation of the sixth DNA base hydroxymethylcytosine in
the brain. Angew. Chem. Int. Ed. Engl., 49, 5375–5377.
5. Szwagierczak,A., Bultmann,S., Schmidt,C.S., Spada,F. and
Leonhardt,H. (2010) Sensitive enzymatic quantiﬁcation of
PAGE 9 OF 10 Nucleic AcidsResearch, 2011, Vol.39,No. 8 e555-hydroxymethylcytosine in genomic DNA. Nucleic Acids Res.,
38, e181.
6. Jin,S.G., Kadam,S. and Pfeifer,G.P. (2010) Examination of the
speciﬁcity of DNA methylation proﬁling techniques towards
5-methylcytosine and 5-hydroxymethylcytosine. Nucleic Acids
Res., 38, e125.
7. Hendrich,B. and Bird,A. (1998) Identiﬁcation and characterization
of a family of mammalian methyl-CpG binding proteins.
Mol. Cell. Biol., 18, 6538–6547.
8. Ito,S., D’Alessio,A.C., Taranova,O.V., Hong,K., Sowers,L.C. and
Zhang,Y. (2010) Role of Tet proteins in 5mC to 5hmC
conversion, ES-cell self-renewal and inner cell mass speciﬁcation.
Nature, 466, 1129–1133.
9. Szwagierczak,A., Bultmann,S., Schmidt,C.S., Spada,F. and
Leonhardt,H. (2010) Sensitive enzymatic quantiﬁcation of
5-hydroxymethylcytosine in genomic DNA. Nucleic Acids Res.,
38, e181.
10. Munzel,M., Globisch,D., Bruckl,T., Wagner,M., Welzmiller,V.,
Michalakis,S., Muller,M., Biel,M. and Carell,T. (2010)
Quantiﬁcation of the sixth DNA base hydroxymethylcytosine
in the brain. Angew. Chem. Int. Ed., 49, 5375–5377.
11. Flusberg,B.A., Webster,D.R., Lee,J.H., Travers,K.J.,
Olivares,E.C., Clark,T.A., Korlach,J. and Turner,S.W. (2010)
Direct detection of DNA methylation during single-molecule,
real-time sequencing. Nat. Methods, 7, 461–465.
12. Nestor,C., Ruzov,A., Meehan,R. and Dunican,D. (2010)
Enzymatic approaches and bisulﬁte sequencing cannot distinguish
between 5-methylcytosine and 5-hydroxymethylcytosine in DNA.
BioTechniques, 48, 317–319.
13. Jin,S.G., Kadam,S. and Pfeifer,G.P. (2010) Examination of the
speciﬁcity of DNA methylation proﬁling techniques towards
5-methylcytosine and 5-hydroxymethylcytosine. Nucleic Acids
Res., 38, e125.
14. Ko,M., Huang,Y., Jankowska,A.M., Pape,U.J., Tahiliani,M.,
Bandukwala,H.S., An,J., Lamperti,E.D., Koh,K.P., Ganetzky,R.
et al. (2010) Impaired hydroxylation of 5-methylcytosine in
myeloid cancers with mutant TET2. Nature, 468, 839–843.
15. Flusberg,B.A., Webster,D.R., Lee,J.H., Travers,K.J.,
Olivares,E.C., Clark,T.A., Korlach,J. and Turner,S.W. (2010)
Direct detection of DNA methylation during single-molecule,
real-time sequencing. Nat. Methods, 7, 461–465.
16. Tomaschewski,J., Gram,H., Crabb,J.W. and Ruger,W. (1985)
T4-induced alpha- and beta-glucosyltransferase: cloning of the
genes and a comparison of their products based on sequencing
data. Nucleic Acids Res., 13, 7551–7568.
17. Georgopoulos,C.P. and Revel,H.R. (1971) Studies with glucosyl
transferase mutants of the T-even bacteriophages. Virology, 44,
271–285.
18. Kornberg,S.R., Zimmerman,S.B. and Kornberg,A. (1961)
Glucosylation of deoxyribonucleic acid by enzymes from
bacteriophage-infected Escherichia coli. J. Biol. Chem., 236,
1487–1493.
19. Gommers-Ampt,J.H., Van Leeuwen,F., de Beer,A.L.,
Vliegenthart,J.F., Dizdaroglu,M., Kowalak,J.A., Crain,P.F. and
Borst,P. (1993) beta-D-glucosyl-hydroxymethyluracil: a novel
modiﬁed base present in the DNA of the parasitic protozoan T.
brucei. Cell, 75, 1129–1136.
20. Borst,P. and Sabatini,R. (2008) Base J: discovery, biosynthesis,
and possible functions. Ann. Rev. Microbiol., 62, 235–251.
21. van Leeuwen,F., Taylor,M.C., Mondragon,A., Moreau,H.,
Gibson,W., Kieft,R. and Borst,P. (1998) beta-D-glucosyl-
hydroxymethyluracil is a conserved DNA modiﬁcation in
kinetoplastid protozoans and is abundant in their telomeres.
Procd. Natl Acad. Sci. USA, 95, 2366–2371.
22. Sabatini,R., Meeuwenoord,N., van Boom,J.H. and Borst,P. (2002)
Recognition of base J in duplex DNA by J-binding protein.
J. Biol. Chem., 277, 958–966.
23. Cross,M., Kieft,R., Sabatini,R., Wilm,M., de Kort,M., van der
Marel,G.A., van Boom,J.H., van Leeuwen,F. and Borst,P. (1999)
The modiﬁed base J is the target for a novel DNA-binding
protein in kinetoplastid protozoans. EMBO J., 18, 6573–6581.
24. Grover,R.K., Pond,S.J., Cui,Q., Subramaniam,P., Case,D.A.,
Millar,D.P. and Wentworth,P. Jr (2007) O-glycoside orientation
is an essential aspect of base J recognition by the kinetoplastid
DNA-binding protein JBP1. Angew. Chem. Int. Ed., 46,
2839–2843.
25. Studier,F.W. (2005) Protein production by auto-induction
in high density shaking cultures. Protein Express. Purif., 41,
207–234.
26. Sambrook,J., Fritsch,E.F. and Maniatis,T. (1989) Molecular
Cloning, A Laboratory Manual, 2nd edn. Cold Spring Harbor
Laboratory Press.
27. Crain,P.F. (1990) Preparation and enzymatic hydrolysis of DNA
and RNA for mass spectrometry. Methods Enzymol., 193,
782–790.
28. Noer,A., Lindeman,L.C. and Collas,P. (2009) Histone H3
modiﬁcations associated with differentiation and long-term
culture of mesenchymal adipose stem cells. Stem Cells Dev., 18,
725–736.
29. Dahl,J.A., Reiner,A.H. and Collas,P. (2009) Fast genomic
muChIP-chip from 1,000 cells. Genome Biol., 10, R13.
e55 Nucleic Acids Research, 2011,Vol. 39,No. 8 PAGE 10 OF 10